LUTALYSE HighCon now available

Zoetis has announced the introduction of LUTALYSE^®HighCon Injection (dinoprost tromethamine injection), a high-concentration formula of the proven LUTALYSE^® Injection (dinoprost injection) approved for use in dairy and beef cattle.

LUTALYSE HighCon delivers the same benefits of LUTALYSE but with some distinguishable improvements:

·

High-concentration formulation-- The higher concentration of LUTALYSE HighCon allows for a 2-mL dose for more convenient administration. More doses per bottle mean fewer bottle changes, too.

·

Subcutaneous administration option -- LUTALYSE HighCon is the first and only prostaglandin on the market approved by the Food and Drug Administration for subcutaneous administration in addition to intramuscular administration. This approval gives producers and veterinarians flexible administration options while allowing them to abide by strict Beef Quality Assurance and Dairy Animal Care and Quality Assurance standards and minimize injection site blemishes.

·

Larger vials --

To fit varying herd management needs, LUTALYSE HighCon is available in three vial sizes — 20 mL, 100 mL and 250 mL. The largest size, 250 mL, allows for the maximum number of doses (125) in one bottle and therefore requires fewer bottles to carry when administering to larger groups of cattle.

Note that LUTALYSE HighCon is approved for use in cattle only, not for equine or swine like LUTALYSE.

Like LUTALYSE, LUTALYSE HighCon is approved for use with FACTREL

to synchronize estrous cycles to allow for fixed-time artificial insemination in lactating dairy cows to achieve higher pregnancy rates and increased milk production. It also gives producers the flexibility to implement many of the popular synchronization programs recommended by the Dairy Cattle Reproduction Council.

Both LUTALYSE and LUTALYSE^®HighCon will remain available to give dairy producers and veterinarians options for what works best for their operations.

Click here to watch a 3-minute video about LUTALYSE HighCon.